According to a Wall Street Journal report, Johnson & Johnson and the U.S. Justice Department are close to settling a lengthy investigation into allegations that the company used illegal tactics in marketing its antipsychotic drug Risperdal.
The report cites unnamed sources who said the settlement would be one of the highest ever in a drug marketing case.
Federal law says drug makers can market medicines only for uses approved by the U.S. ...
continue reading...
In a recent article, The Motley Fool writer Catherine Baab-Muguira addresses a number of recent management errors and product recalls at Johnson & Johnson.
She writes that they’ve “had investors scratching their heads and asking: Is Johnson & Johnson broken?”
The Department of Justice filed a civil False Claims Act against Johnson & Johnson in 2010, alleging that the company had illegally paid kickbacks to nursing-home pharmaceutical supplier Omnicare to induce Omnicare ...
continue reading...Johnson & Johnson officials hope the $19.7 billion acquisition of Synthes, which makes surgical trauma equipment and orthopedic implants, will give the company a dominant position in the orthopedic surgery market.
According to a Bloomberg report, Johnson & Johnson’s prescription drugs and consumer health segments have both suffered revenue losses in recent years following a series of recalls.
Johnson & Johnson has launched about two dozen recalls of nonprescription drugs and at ...
continue reading...
Bloomberg reports that Johnson & Johnson has agreed to pay as much as $2.2 billion to settle federal government investigations into claims that the company illegally marketed antipsychotic drug Risperdal and other medications.
The report quotes unnamed sources as saying the settlement will include a misdemeanor plea and a criminal penalty of as much as $600 million.
But that wouldn’t be the end of Johnson & Johnson’s legal troubles. The company is ...
continue reading...
One of the dangers of transvaginal mesh devices, according to an article in The Trial Lawyer magazine, is that they typically can’t be removed once they’ve been implanted in a patient’s body.
This is bad news for the thousands of implant recipients who have reported problems including debilitating pain and organ perforation after the devices have started to erode. According to The Trial Lawyer, doctors can trim ...
continue reading...
